Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 14, 2026

Trump Hosts Brutal UFC Fights at White House for 80th Birthday

View original at finance.yahoo.com
Trump Hosts Brutal UFC Fights at White House for 80th Birthday (Bloomberg) -- Donald Trump will head to France for what will likely be contentious discussions with world leaders this week, but first he'll celebrate his 80th birthday by watching a sport that's more brutal and bloody than politics…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The UFC Freedom 250 White House event was Donald Trump's idea

    60% confidence
  • The White House UFC event constitutes a 'volcano of corruption'

    60% confidence
  • UFC Freedom 250 will be the greatest earned marketing tool of all time despite operating at a financial loss

    60% confidence
  • 51% of Americans surveyed disapproved of holding the UFC fight at the White House, while only 27% approved

    60% confidence
  • UFC Freedom 250 will be a money-loser for UFC

    60% confidence
  • UFC is covering the entire cost of the White House event and has handled all sponsorship discussions

    60% confidence

Data points we hold from this source

Donald Trump · parameter count80 years_age
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com